Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
honey bee hymenoptera venom
- Development stage
- Approved
- Lead developer
- Jubilant HollisterStier
- Administration
- Subcutaneous, Topical, Intradermal
01
Overview
**Honey bee hymenoptera venom** is a sterile lyophilized biologic allergenic extract derived from *Apis mellifera* venom and used for both diagnosis of honey bee venom hypersensitivity and venom immunotherapy to reduce the risk of systemic allergic reactions after future bee stings. It is supplied as a freeze-dried powder for reconstitution, administered primarily by subcutaneous injection for immunotherapy and by percutaneous or intradermal skin testing for diagnosis. Its therapeutic effect is mediated not by blockade of a single molecular receptor, but by controlled exposure to whole bee venom allergens that modulates the patient's venom-specific immune response, reducing pathologic IgE-mediated reactivity and promoting clinical desensitization. The product has been marketed in the United States, including under the Venomil brand, and is manufactured by Jubilant HollisterStier.
- Brand names
- Venomil
- Other names
- Honey Bee VenomApis mellifera venomhoney bee venom allergenic extracthoney bee hymenoptera venom
02
Targets
IgE (Immunoglobulin E)
Beyond the preview
Go deeper on honey bee hymenoptera venom.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on honey bee hymenoptera venom.